menu
    • menu

    Company profile for BrainStorm Cell Therapeutics

    NEW Drugs in Dev: 5
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative disorders such as ALS (Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s disease (PD). These diseases have limited treatment options and as such represent unmet medical needs. NurOwn™ is BrainStorm’s proprietary process for the propagation...
    BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative disorders such as ALS (Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s disease (PD). These diseases have limited treatment options and as such represent unmet medical needs. NurOwn™ is BrainStorm’s proprietary process for the propagation and differentiation of adult, autologous mesenchymal stem cells (MSC) into neurotrophic factor (NTF)-secreting cells, and the transplantation of these specialized cells at or near the affected tissue site.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BrainStorm Cell TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3 University Plaza Drive Suite 320 Hackensack, NJ 07601
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://brainstorm-cell.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/brainstorm-cell-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/BrainStormCell

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BrainStorm Taps Ex-FDA Leader Peter Pitts for ALS Program
    BrainStorm Taps Ex-FDA Leader Peter Pitts for ALS Program

    02 Jun 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/brainstorm-levels-up-bringing-on-former-fda-leader-peter-pitts-for-new-als-bid

    BIOSPACE
    02 Jun 2026
    Share Share
    BrainStorm Appoints Peter Pitts to Board of Directors
    BrainStorm Appoints Peter Pitts to Board of Directors

    28 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-appoints-former-fda-associate-commissioner-peter-j-pitts-to-board-of-directors-302784278.html

    PR NEWSWIRE
    28 May 2026
    Share Share
    Lunai, BrainStorm Launch AI Drug Discovery Collaboration
    Lunai, BrainStorm Launch AI Drug Discovery Collaboration

    28 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lunai-bioworks-and-brainstorm-therapeutics-launch-foundation-funded-parkinsons-and-rare-epilepsy-ai-discovery-collaboration-302784369.html

    PR NEWSWIRE
    28 May 2026
    Share Share
    BrainStorm Cell Therapeutics Reports Q1 2026 Financial Results
    BrainStorm Cell Therapeutics Reports Q1 2026 Financial Results

    15 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-announces-first-quarter-2026-financial-results-and-provides-corporate-update-302773613.html

    PR NEWSWIRE
    15 May 2026
    Share Share
    Brainstorm Cell Therapeutics Reveals 2025 Financials, Updates
    Brainstorm Cell Therapeutics Reveals 2025 Financials, Updates

    01 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-announces-full-year-2025-financial-results-and-provides-corporate-update-302730443.html

    PR NEWSWIRE
    01 Apr 2026
    Share Share
    Brainstorm Cell Therapeutics Reveals Q3 2025 Financials Update
    Brainstorm Cell Therapeutics Reveals Q3 2025 Financials Update

    15 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-announces-third-quarter-2025-financial-results-and-provides-corporate-update-302615557.html

    PR NEWSWIRE
    15 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search